openPR Logo
Press release

Projected Market Growth for Diffuse Large B-cell Lymphoma Therapeutics: Key Trends, Major Players, and Forecast for 2024-2029

01-23-2025 02:17 PM CET | Health & Medicine

Press release from: The Business Research Company

Diffuse Large B-cell Lymphoma Therapeutics Market Outlook

Diffuse Large B-cell Lymphoma Therapeutics Market Outlook

Unprecedented growth of the Diffuse Large B-cell Lymphoma Therapeutics market is projected for the next decade, characterized by therapeutic advancements, strategic collaborations, and a rising patient population.

What Is The Projected Market Size Of The Global Diffuse Large B-cell Lymphoma Therapeutics Market And Its Growth Rate?
The diffuse large B-cell lymphoma therapeutics market has been growing at a significant pace, fueled by advances in clinical research, patient awareness, and evolving standards of care.
• 2024 Market Size: $4.74 billion
• 2025 Market Size: $5.15 billion (CAGR of 8.5%)
• 2029 Projected Market Size: $7.05 billion (CAGR of 8.2%)
This growth can be attributed to factors such as biomarker discovery, improvements in immunotherapy, rising incidence rates, an aging global population, development of healthcare infrastructure, and broader access to novel drugs.

What Is Driving The Growth In The Diffuse Large B-cell Lymphoma Therapeutics Market?
The increasing incidence of diffuse large B-cell lymphoma (DLBCL) signifies the major driver for the growth of the market. DLBCL is an aggressively growing cancer originating from B-cells in the lymphatic system. Approximated diagnosis by the American Cancer Society reveals about 80,550 people (44,880 males and 35,670 females) will be diagnosed with non-Hodgkin's lymphoma (NHL) by 2023, where about 20,180 people will lose their lives. The escalating incidence contributes directly to the rise in the DLBCL therapeutics market.

Request A Free Sample Copy:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10805&type=smp

Who Are the Key Players Driving Diffuse Large B-cell Lymphoma Therapeutics Market Growth?
The following key players are driving market growth:
• Novartis AG
• Pfizer Inc.
• Merck & Co Inc.
• GlaxoSmithKline plc
• F. Hoffmann-La Roche AG
• CTI BioPharma Corp.
• Celltrion Healthcare Co Ltd.
• Bristol-Myers Squibb Company
• AbbVie Inc.
• Gilead Sciences Inc.
• Seagen Inc.
• Kite Pharma Inc.
• ADC Therapeutics SA
• Bayer AG
• Xencor Inc.
• Autolus Therapeutics plc
• Allogene Therapeutics Inc.
• Spectrum Pharmaceuticals Inc.
• AstraZeneca PLC
• Aptevo Therapeutics Inc.
• Takeda Pharmaceutical Company Limited
• Johnson & Johnson
• Celgene Corporation
• Eli Lilly and Company
• Sanofi SA
• Seattle Genetics Inc.
• Karyopharm Therapeutics Inc.
• TG Therapeutics Inc.
• MorphoSys AG

What Are The Key Trends In The Diffuse Large B-cell Lymphoma Therapeutics Market?
Key trends forecasted in the market include:
• Patient-centric care models
• Outpatient treatment settings
• Collaborative clinical trials
• Diagnostic imaging advancements
• Healthcare digitalization

What Are The Segments Of The Global Diffuse Large B-cell Lymphoma Therapeutics Market?
The market can be segmented as follows:
1) By Drug Class: Cisplatin, Carboplatin, 5-fluorouracil, Docetaxel, Paclitaxel, Methotrexate, Other Drugs
2) By Therapy: Targeted Therapy, Immunotherapy, Chemotherapy, Other Therapies
3) By Route of Administration: Oral, Parenteral, Other Routes
4) By End User: Hospitals, Clinics, Other End-Users

Which Region Leads The Diffuse Large B-cell Lymphoma Therapeutics Market?
North America held the largest share in the global diffuse large B-cell lymphoma therapeutics market in 2024. Meanwhile, the Asia-Pacific region is presumed to witness the swiftest growth in the forecast period encompassing countries from Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Pre-book the Report for Swift Delivery:
https://www.thebusinessresearchcompany.com/report/diffuse-large-b-cell-lymphoma-therapeutics-global-market-report

What Is Covered In The Diffuse Large B-cell Lymphoma Therapeutics Market Global Market Report?
- Market Size Analysis: Analyze the Diffuse Large B-cell Lymphoma Therapeutics Market size by key regions, countries, product types, and applications.

- Market Segmentation Analysis: Identify various subsegments within the Diffuse Large B-cell Lymphoma Therapeutics Market for effective categorization.

- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape.

- Growth Trends Analysis: Examine individual growth trends and prospects in the Market.

- Market Contribution: Evaluate contributions of different segments to the overall Diffuse Large B-cell Lymphoma Therapeutics Market growth.

- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers.

- Industry Challenges: Analyze challenges and risks affecting the Diffuse Large B-cell Lymphoma Therapeutics Market.

- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market.

Request Customization for This Report:
https://www.thebusinessresearchcompany.com/Customise?id=10805&type=smp

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Projected Market Growth for Diffuse Large B-cell Lymphoma Therapeutics: Key Trends, Major Players, and Forecast for 2024-2029 here

News-ID: 3830276 • Views:

More Releases from The Business Research Company

Automatic Swing Door Operators: Critical Driver Shaping the The Increasing Adoption Of The Internet Of Things Is Driving The Growth Of The Market Due To Enhanced Automation And Efficiency Market in 2025
Automatic Swing Door Operators: Critical Driver Shaping the The Increasing Adopt …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Automatic Swing Door Operators Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for automatic swing door operators has seen significant expansion over the past few years. The market is projected to rise from $1.77 billion in 2024 to $1.91 billion in 2025, reflecting
Automated Teller Machine Outsourcing Sales Market Expansion Continues, with Forecast Valuation of $4.16 Billion by 2029
Automated Teller Machine Outsourcing Sales Market Expansion Continues, with Fore …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Automated Teller Machine Outsourcing Sales Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market size for automated teller machines outsourcing sales has significantly increased in the past few years. The total value is predicted to expand from $2.84 billion in 2024 to $3.07 billion
Comprehensive Autoclaved Lightweight Concrete (ALC) Market Forecast 2025-2034: Growth Trends and Strategic Shifts
Comprehensive Autoclaved Lightweight Concrete (ALC) Market Forecast 2025-2034: G …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Autoclaved Lightweight Concrete (ALC) Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In the past few years, the market size of autoclaved lightweight concrete (ALC) has experienced significant growth. There is an expected increase from $8.02 billion in 2024 to $8.60 billion in 2025, with
Emerging Trends to Reshape the Architecture Clear Float Glass Market: Advanced Coated Glass Innovations Driving Performance And Sustainability In Modern Construction as a Key Influencer
Emerging Trends to Reshape the Architecture Clear Float Glass Market: Advanced C …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Architecture Clear Float Glass Market Size Valuation Forecast: What Will the Market Be Worth by 2025? In recent times, the market size for clear float glass used in architecture has seen significant growth. The market, pegged at $23.91 billion in 2024, is projected to expand to $25.32 billion in

All 5 Releases


More Releases for Therapeutics

Adrenomyeloneuropathy Market: Epidemiology, Therapies, Companies, DelveInsight | …
Adrenomyeloneuropathy emerging therapies are expected to boost the Adrenomyeloneuropathy Market in the upcoming years. DelveInsight has launched a new report on "Adrenomyeloneuropathy - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Adrenomyeloneuropathy, historical and forecasted epidemiology as well as the Adrenomyeloneuropathy market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Discover about the Adrenomyeloneuropathy market report @ https://www.delveinsight.com/report-store/adrenomyeloneuropathy-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=kpr Some of the
Pompe Disease Market: Epidemiology, Therapies, Companies, DelveInsight | Genzyme …
Pompe Disease emerging therapies, such as MYOZYME (alglucosidase alfa), LUMIZYME, AAV2/8-LSPhGAA, Avalglucosidase alfa, and others, are expected to boost the Pompe Disease Market in the upcoming years. DelveInsight has launched a new report on "Pompe Disease - Market Insights, Epidemiology, and Market Forecast-2034" that delivers an in-depth understanding of the Pompe Disease, historical and forecasted epidemiology as well as the Pompe Disease market trends in the United States, EU5 (Germany, Spain,
Dark Genome Therapeutics Market Deep Research Report with Forecast to 2032 | myN …
The qualitative latest Research report (2025-2032) on the Dark Genome Therapeutics Market by Coherent Market Insights Provides a deep dive into key market trends, drivers, challenges, and the competitive landscape. It analyzes market size, revenue, production, and CAGR using validated methodologies to ensure precision. The report highlights tech innovation, pricing trends, consumer behavior, and investment potential - empowering businesses to make informed, strategic moves. Request a Sample Copy: https://www.coherentmarketresearch.com/samplepages/133611 Focused on growth
Hodgkin's lymphoma Therapeutics Market Size Report 2032 | Affimed Therapeutics, …
DelveInsight's "Hodgkin's Lymphoma Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Hodgkin's Lymphoma, historical and forecasted epidemiology as well as the Hodgkin's Lymphoma market trends in the United States, EU4 (Germany, Spain, Italy, and France) and the United kingdom and Japan. Discover Key Insights into the Hodgkin's lymphoma Market with DelveInsight's In-Depth Report @ Hodgkin's lymphoma Market Size- https://www.delveinsight.com/sample-request/hodgkins-lymphoma-hl-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr Key Takeaways from the Hodgkin's
CRISPR Therapies Pipeline 2024 | Intellia Therapeutics, CRISPR therapeutics, Rep …
DelveInsight's, "CRISPR Therapies Pipeline Insight 2024" report provides comprehensive insights about 25+ CRISPR Therapies Companies and 30+ pipeline drugs in CRISPR Therapies pipeline landscape. It covers the CRISPR Therapies pipeline drug profiles, including clinical and nonclinical stage products. It also covers the CRISPR Therapies therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive CRISPR Therapies pipeline products in this space. Key Takeaways from
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025. North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant